To participate in Aspire I, members of the Board of Management and other senior executives are required to purchase a certain number of Bayer shares that is predetermined according to specific guidelines and to retain them for the full term of the program. A percentage of the executive’s annual base salary – based on his/her position – is defined as a target for variable payments (Aspire target opportunity). Depending on the performance of Bayer stock, both in absolute terms and relative to the Dow Jones EURO STOXX 50SM benchmark index over a three-year performance period, participants are granted an award of up to 200% of their individual Aspire target opportunity at the end of the program.
Aspire performance periods start on January 1st and end on December 31st of the next but one year (3 years in total).
A variant of the Aspire program with the following modifications is also offered to middle management: